Online Program Home
  My Program
CC = Baltimore Convention Center,    H = Hilton Baltimore
* = applied session       ! = JSM meeting theme

Activity Details

208 * ! Mon, 7/31/2017, 2:00 PM - 3:50 PM CC-322
Substantial Evidence Using Bayesian Statistics in New Drug Approvals — Invited Papers
Section on Bayesian Statistical Science , Health Policy Statistics Section , Statistics and Public Policy
Organizer(s): Fanni Natanegara, Eli Lilly and Company
Chair(s): Fanni Natanegara, Eli Lilly and Company
2:05 PM A Global Oncology Platform Trial for Personalized Medicine: GBM AGILE Jason Connor, Berry Consultants
2:20 PM Predictive Evidence Threshold Scaling: Does the Evidence Meet a Confirmatory Standard? Satrajit Roychoudhury, Pfizer Inc ; Beat Neuenschwander, Novartis Pharma AG ; Michael Branson, Novartis Pharma AG
2:35 PM Shedding a Bayesian Light on the Evidence-Based Medicine J. Jack Lee, UT MD Anderson Cancer Ctr.
2:50 PM Re-Analyzing Clinical Trials Through the Bayesian Lens Margaret Gamalo-Siebers, Eli Lilly ; Karen Price, Eli Lilly ; Stephen J Ruberg, Eli Lilly and Co
3:05 PM Discussant: Stephen J Ruberg, Eli Lilly and Co
3:20 PM Discussant: John Scott, FDA
3:35 PM Floor Discussion
Copyright © American Statistical Association